Non-treated IDH1 mutant glioma cells produce an excess of 2-HG relative to wild type glioma cells (7.8 fold; p < 0.001); 2-HG levels increased further after 5-ALA treatment (1.7 fold; p < 0.005). This evidence concerns the gene IDH1 and central nervous system cancer.